BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23106744)

  • 1. Novel approaches to epilepsy treatment.
    Sørensen AT; Kokaia M
    Epilepsia; 2013 Jan; 54(1):1-10. PubMed ID: 23106744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell and gene therapies in epilepsy--promising avenues or blind alleys?
    Löscher W; Gernert M; Heinemann U
    Trends Neurosci; 2008 Feb; 31(2):62-73. PubMed ID: 18201772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
    Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
    Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for epilepsy.
    Simonato M
    Epilepsy Behav; 2014 Sep; 38():125-30. PubMed ID: 24100249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy.
    McCown TJ
    Drug News Perspect; 2010 Jun; 23(5):281-6. PubMed ID: 20603651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical potential of antiepileptic gene therapy.
    McCown TJ
    Expert Opin Biol Ther; 2004 Nov; 4(11):1771-6. PubMed ID: 15500405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy in epilepsy.
    Riban V; Fitzsimons HL; During MJ
    Epilepsia; 2009 Jan; 50(1):24-32. PubMed ID: 18717707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptides in epilepsy.
    Kovac S; Walker MC
    Neuropeptides; 2013 Dec; 47(6):467-75. PubMed ID: 24210141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the unmet treatment need in partial-onset epilepsy: looking beyond seizure control.
    Schmitz B; Montouris G; Schäuble B; Caleo S
    Epilepsia; 2010 Nov; 51(11):2231-40. PubMed ID: 20973782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of gene therapy for the treatment of epilepsy.
    Vezzani A
    Expert Rev Neurother; 2007 Dec; 7(12):1685-92. PubMed ID: 18052764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vagal nerve stimulation in children with drug-resistant epilepsy].
    Bremer A; Eriksson AS; Røste GK; Knudtzen B; Nakken KO
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):896-8. PubMed ID: 16554878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.
    Potschka H
    Adv Drug Deliv Rev; 2012 Jul; 64(10):943-52. PubMed ID: 22210135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal treatment for refractory epilepsy: hope for the future?
    Nilsen KE; Cock HR
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):141-53. PubMed ID: 15003390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing the management of childhood epilepsies.
    Cross JH; Kluger G; Lagae L
    Eur J Paediatr Neurol; 2013 Jul; 17(4):334-47. PubMed ID: 23558251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies.
    Cersósimo RO; Bartuluchi M; Fortini S; Soraru A; Pomata H; Caraballo RH
    Epileptic Disord; 2011 Dec; 13(4):382-8. PubMed ID: 22258042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of vagus nerve stimulation for epilepsy in Budapest.
    Müller K; Fabó D; Entz L; Kelemen A; Halász P; Rásonyi G; Eross L
    Epilepsia; 2010 Jul; 51 Suppl 3():98-101. PubMed ID: 20618411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment protocol for long-term anti-epilepsy drugs in adults with refractory partial epilepsy].
    Thomas P
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S252-64. PubMed ID: 15331973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat.
    Nilsen KE; Walker MC; Cock HR
    Epilepsia; 2005 Feb; 46(2):179-87. PubMed ID: 15679498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
    Boison D
    Neurodegener Dis; 2007; 4(1):28-33. PubMed ID: 17429216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of focal epilepsy.
    De Deyn PP; D'Hooge R
    Acta Neurol Belg; 1999 Dec; 99(4):222-5. PubMed ID: 10674138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.